China catheters market is expected to grow at a CAGR of around 9.8% during the forecast period. The growing penetration rate of PTCA balloon catheter and Central Venous catheter is considered as a major driving factor for Chinese catheter market. PTCA is a minimally invasive procedure used to remove the blockage of coronary arteries, thereby permitting blood flow to the heart muscles. The procedure involves the placement of the PTCA balloon catheter to compress and clear the blockage by widening the artery. PTCA balloon catheter was first of its kind used in the field of cardiology. It is also used to position stents in angioplasty. Abbott Laboratories, Medtronic, Terumo, Microport scientific and Boston scientific are major key vendors in the market.
Chinese coronary stent manufacturers have sharpened the edge in the production of the PTCA balloon catheter. Lepu Medical, Microport and Beijing Fuji Sunshine Technology are well known coronary stent suppliers in china. Rising prevalence of CVD is contributing to the adoption of catheters in the country. As per the estimation by the World Heart Federation, one in 5 adults in China has a CVD. China government is also taking positive steps to improve healthcare infrastructure by reducing the prevalence of heart diseases. The government is increasing access to healthcare by broadening the reach of its health insurance schemes and spending on training hospital staff. Phillips is working with Chinese society of Cardiology to build China National Cardiovascular Data Repository, which enables doctors to conduct clinical research, product development and provide better healthcare facilities to China’s 270 million heart patients. Such kinds of initiatives are boosting the demand for minimally invasive treatment alternatives for patients and thereby will accelerate the market.
The major companies operating in the region include Abbott Laboratories, Inc., Boston Scientific Corp., and Medtronic plc. To survive in the market, these players are adopting crucial strategies, such as mergers and acquisitions, product launches, and partnerships and collaborations. This enables the company to increase its competitiveness and attract significant share in the market. For instance, in September 2016, Intuitive Surgical and Fosun Pharma established Joint Venture with the purpose to research, develop and manufacture advanced, robotic-assisted catheter-based medical instruments. This move aimed to deliver advanced healthcare solutions in China and across the globe.
Research Methodology
The market study of the China catheters market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.
Secondary Sources Include:
The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation:
The Report covers:
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. China Catheters Market by Product Type
5.1.1. Cardiovascular Catheters
5.1.2. Urological Catheters
5.1.3. Intravenous Catheters
5.1.4. Specialty Catheters
5.1.5. Neurovascular Catheters
6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.2. Becton Dickinson and Co.
6.3. Boston Scientific Corp.
6.4. Edwards Lifesciences Corp.
6.5. Integra Lifesciences Corp.
6.6. Johnson & Johnson Services, Inc.
6.7. Koninklijke Philips N.V.
6.8. Medtronic plc
6.9. Stryker Corp.
6.10. Terumo Medical Corp.
1. CHINA CATHETERS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
1. CHINA CATHETERS MARKET SHARE BY PRODUCT TYPE, 2018 VS 2025 (%)